# The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to severe COVID-19 in the Iranian population

**Authors:** Narges Karami, Shaghik Barani, Mona Fani, Seppo Meri, Reza Shafiei, Kurosh Kalantar

PMC · DOI: 10.1186/s12865-024-00631-1 · 2024-06-28

## TL;DR

This study explores how specific KIR genes influence the severity of COVID-19 in Iranians, finding some genes may protect against severe disease.

## Contribution

The study identifies specific KIR genes and haplotypes associated with mild or severe COVID-19 in the Iranian population.

## Key findings

- KIR2DS1 and KIR2DS2 genes are more common in mild cases, suggesting a protective role.
- KIR3DL3 and KIR2DS4 are more frequent in severe cases, indicating increased risk.
- B haplotype is linked to milder disease, while haplotype A is associated with severity.

## Abstract

Variations in the innate and adaptive immune response systems are linked to variations in the severity of COVID-19. Natural killer cell (NK) function is regulated by sophisticated receptor system including Killer-cell immunoglobulin-like receptor (KIR) family. We aimed to investigate the impact of possessing certain KIR genes and genotypes on COVID19 severity in Iranians. KIR genotyping was performed on 394 age/sex matched Iranians with no underlying conditions who developed mild and severe COVID- 19. The presence and/or absence of 11 KIR genes were determined using the PCR with sequence specific primers (PCR-SSP).

Patients with mild symptoms had higher frequency ofKIR2DS1 (p = 0.004) and KIR2DS2 (p = 0.017) genes compared to those with severe disease. While KIR3DL3 and deleted variant of KIR2DS4 occurred more frequently in patients who developed a severe form of the disease. In this study, a significant increase of and B haplotype was observed in the Mild group compared to the Severe group (respectively, p = 0.002 and p = 0.02). Also, the prevalence of haplotype A was significantly higher in the Severe group than in the Mild group (p = 0.02).

These results suggest that the KIR2DS1, KIR2DS, and B haplotype maybe have a protective effect against COVID-19 severity. The results also suggest the inhibitory gene KIR2DL3 and haplotype A are risk factors for the severity of COVID-19.

The online version contains supplementary material available at 10.1186/s12865-024-00631-1.

## Linked entities

- **Genes:** KIR2DS1 (killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1) [NCBI Gene 3806], KIR2DS2 (killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2) [NCBI Gene 100132285], KIR3DL3 (killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 3) [NCBI Gene 115653], KIR2DS4 (killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4 (gene/pseudogene)) [NCBI Gene 3809], KIR2DL3 (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3) [NCBI Gene 3804]
- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Genes:** KIR3DL3 (killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 3) [NCBI Gene 115653] {aka CD158Z, KIR3DL7, KIR44, KIRC1}, KIR2DS2 (killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2) [NCBI Gene 100132285] {aka 183ActI, CD158J, CD158b, KIR-2DS2, NKAT-5, NKAT5}, KIR2DS1 (killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1) [NCBI Gene 3806] {aka CD158H, CD158a, p50.1}, KIR2DS4 (killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4 (gene/pseudogene)) [NCBI Gene 3809] {aka CD158I, KIR-2DS4, KIR1D, KIR412, KKA3, NKAT-8}, KIR2DL3 (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3) [NCBI Gene 3804] {aka CD158B2, CD158b, GL183, KIR-023GB, KIR-K7b, KIR-K7c}
- **Diseases:** COVID- 19 (MESH:D000086382)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11212229/full.md

---
Source: https://tomesphere.com/paper/PMC11212229